Nektar Therapeutics NKTR
NASDAQ NKTR
$59.29 -1.11 (-1.84%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nektar Therapeutics (NKTR) Total Current Liabilities (2010 - 2026)

Updated

Nektar Therapeutics' Total Current Liabilities came in at $70.99 million for Q2 2026, down 0.6% from $71.39 million a year earlier but up 23.0% from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Nektar Therapeutics' Total Current Liabilities was $53.54 million, down 12.8% from FY2024.

  • Total Current Liabilities carries a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $61.4 million in FY2024 (+19.8%), $51.27 million in FY2023 (-24.8%), $68.2 million in FY2022 (-19.9%) and $85.2 million in FY2021 (-26.4%).
  • The five-year range for quarterly Total Current Liabilities is $50.69 million (Q2 2023) to $139.97 million (Q3 2021).
  • Year-over-year, Total Current Liabilities has declined for four consecutive quarters, with growth averaging 9.4% over the last eight quarters.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q1 2025 (growth of 35.3%), and the weakest in Q2 2023 (a decline of 51.7%).
  • Business Quant data shows NKTR's Total Current Liabilities at $57.71 million (Q1 2026), $53.54 million (Q4 2025) and $66.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Nektar Therapeutics 2.00 Bn 227.61 Mn - 70.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.99 Mn
Mar 31, 2026 57.71 Mn
Dec 31, 2025 53.54 Mn
Sep 30, 2025 66.34 Mn
Jun 30, 2025 71.39 Mn
Mar 31, 2025 70.93 Mn
Dec 31, 2024 61.40 Mn
Sep 30, 2024 67.58 Mn
Jun 30, 2024 57.33 Mn
Mar 31, 2024 52.41 Mn
Dec 31, 2023 51.27 Mn
Sep 30, 2023 52.11 Mn
Jun 30, 2023 50.69 Mn
Mar 31, 2023 59.88 Mn
Dec 31, 2022 68.20 Mn
Sep 30, 2022 83.99 Mn
Jun 30, 2022 104.99 Mn
Mar 31, 2022 105.28 Mn
Dec 31, 2021 85.20 Mn
Sep 30, 2021 139.97 Mn
API Access

Nektar Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NKTR&period=max&api_key=YOUR_API_KEY